Thomas N. Konatich
Keine laufenden Positionen mehr
Profil
Thomas N.
Konatich was Vice President, Chief Financial Officer and Treasurer of SIGA Technologies, Inc. from April 1, 1998 to January 2009 and Secretary from June 29, 2001 to January 2009.
From 1993 to November 1996, he was Vice President and Chief Financial Officer of Seragen, Inc. From October 5, 2001 to July 2, 2004 and from May 1, 2006 to February 28, 2007, Mr. Konatich was an Acting Chief Executive Officer of SIGA Technologies and Chief Financial Officer and a Director of Innapharma, Inc. from November 1996 to March 1998.
He received an MBA from the Columbia Graduate School of Business.
Ehemalige bekannte Positionen von Thomas N. Konatich
| Unternehmen | Position | Ende |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Finanzdirektor/CFO | 31.01.2009 |
Innapharma, Inc. (New York)
 Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Finanzdirektor/CFO | 01.03.1998 |
Seragen, Inc.
 Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Finanzdirektor/CFO | 01.11.1996 |
Ausbildung von Thomas N. Konatich
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
Innapharma, Inc. (New York)
Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Commercial Services |
